Condition: Schizophrenia · Sponsor: Neurocrine Biosciences
This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.
This description comes directly from the study's public registry record.
Neurocrine Medical Information Call Center · 877-641-3461 · medinfo@neurocrine.com
Always discuss trial participation with your own doctor first.
| Neurocrine Clinical Site | Bryant, Arkansas, United States | Recruiting |
| Neurocrine Clinical Site | Little Rock, Arkansas, United States | Recruiting |
| Neurocrine Clinical Site | Cerritos, California, United States | Recruiting |
| Neurocrine Clinical Site | Chino, California, United States | Recruiting |
| Neurocrine Clinical Site | Culver City, California, United States | Recruiting |
| Neurocrine Clinical Site | Garden Grove, California, United States | Recruiting |
| Neurocrine Clinical Site | La Habra, California, United States | Recruiting |
| Neurocrine Clinical Site | Lemon Grove, California, United States | Recruiting |
| Neurocrine Clinical Site | Oceanside, California, United States | Recruiting |
| Neurocrine Clinical Site | Pico Rivera, California, United States | Recruiting |
| Neurocrine Clinical Site | Riverside, California, United States | Recruiting |
| Neurocrine Clinical Site | San Diego, California, United States | Recruiting |
+ 45 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.